FT News Briefing

The year of weight-loss drugs

Chancellor Jeremy Hunt raised the prospect of the Bank of England reducing interest rates in 2024 in an interview with the FT, and Novo Nordisk’s drugs for obesity could have a profound effect on healthcare, society and our relationship with food. Plus, part three or our three-part series on a changing India looks at the country’s booming fertility industry.  Mentioned in this podcast:<a href="https://on.ft.com/3Rs2rLw" rel="noopener noreferrer" target="_blank">FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk</a><a href="https://on.ft.com/483YBiX" rel="noopener noreferrer" target="_blank">Jeremy Hunt raises prospect of Bank of England rate cuts in 2024</a>Credit: Vogue.comCredit: Jimmy Kimmel Live The FT News Briefing is produced by Fiona Symon, Sonja Hutson, Kasia Broussalian and Marc Filippino. Additional help by Breen Turner, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Our engineer is Monica Lopez. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music. <a href="https://www.ft.com/content/698c4a63-ee42-4847-a9ac-798c5567cdc0" rel="noopener noreferrer" target="_blank">Read a transcript of this episode on FT.com</a> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.

A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.